Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer

Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer

Carcinoembryonic antigen (CEA) is widely used to evaluate the effectiveness of treatment in patients with rectal cancer.The aim of the study was to investigate whether the CEA levels measured before and after neoadjuvant chemoradiotherapy (nCRT) can be used to predict pathological complete response...

Full description

Bibliographic Details
Main Authors: N. V. Severskaya, D. V. Erygin, Yu. V. Aleksandrov, N. G. Minaeva, N. Yu. Dvinskikh, N. Yu. Novikov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2018-11-01
Series:Сибирский онкологический журнал
Subjects:
rectal cancer
cea
tumor regression grade
pathological complete response
neo-adjuvant chemoradiotherapy
Online Access:https://www.siboncoj.ru/jour/article/view/859

Similar Items

Similar Items